BackClovis Oncology Overview

Clovis Oncology Long-Term Investments

Latest long-term investments for CLVS: $240M.

Get informed when a big investor buys or sells

+ Follow
Long-Term Investments
$244.57M
11.81% YoYΔ $-32.77M vs prior year quarter

Peer trimmed avg / median

Loading

Clovis Oncology Long-Term Investments History

Loading

Clovis Oncology vs. peers: Long-Term Investments Comparison

Loading

Clovis Oncology Long-Term Investments Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Clovis Oncology (CLVS) FAQ

As of the most recent data (September 2022), CLVS shows a long-term investments of $240M. That compares with $280M in the prior-year period — down 11.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CLVS's long-term investments is now $240M (was $280M) — a 11.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Clovis Oncology is outperforming or lagging.

Tracking CLVS's long-term investments over time shows whether Clovis Oncology is scaling, shrinking, or reshaping that part of the business. The current reading is $240M That compares with $280M in the prior-year period — down 11.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term investments page, Stockcircle has Clovis Oncology's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term investments (currently $240M) with ownership activity and broader fundamentals.

Clovis Oncology's long-term investments is $240M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.